These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27350533)

  • 1. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
    Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
    Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB.
    Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N
    Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain drug delivery of small molecules using immunoliposomes.
    Huwyler J; Wu D; Pardridge WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Lipoprotein Receptor Targeted Echinacoside-Liposomes Effective Against Parkinson's Disease in Mice Model.
    Ou Z; You Y; Yi H; Liu X; Tong Y; Liu D; Wang J
    Int J Nanomedicine; 2024; 19():8463-8483. PubMed ID: 39185346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
    Zhang Y; Calon F; Zhu C; Boado RJ; Pardridge WM
    Hum Gene Ther; 2003 Jan; 14(1):1-12. PubMed ID: 12573054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):129-38. PubMed ID: 15717064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease.
    Qu M; Lin Q; Huang L; Fu Y; Wang L; He S; Fu Y; Yang S; Zhang Z; Zhang L; Sun X
    J Control Release; 2018 Oct; 287():156-166. PubMed ID: 30165139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes.
    Zhang YF; Boado RJ; Pardridge WM
    Pharm Res; 2003 Nov; 20(11):1779-85. PubMed ID: 14661922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
    Gosk S; Vermehren C; Storm G; Moos T
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
    Pahuja R; Seth K; Shukla A; Shukla RK; Bhatnagar P; Chauhan LK; Saxena PN; Arun J; Chaudhari BP; Patel DK; Singh SP; Shukla R; Khanna VK; Kumar P; Chaturvedi RK; Gupta KC
    ACS Nano; 2015 May; 9(5):4850-71. PubMed ID: 25825926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
    Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
    Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A brain targeting functionalized liposomes of the dopamine derivative N-3,4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease.
    Qu M; Lin Q; He S; Wang L; Fu Y; Zhang Z; Zhang L
    J Control Release; 2018 May; 277():173-182. PubMed ID: 29588159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-conjugated liposomes of dopamine hydrochloride for effective management of parkinsonism's.
    Khare P; Jain A; Jain NK; Soni V; Jain SK
    PDA J Pharm Sci Technol; 2009; 63(5):372-9. PubMed ID: 20158043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated immunoliposomes directed against brain astrocytes.
    Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
    Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
    Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
    Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Future Sci OA; 2015 Nov; 1(4):FSO71. PubMed ID: 28031922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of brain targeted immunoliposomes].
    Zhao H; Wang RZ; Wang F; Zhang YH; Chen XW; Li XR; Liu Y; Li GL; Wei JJ; Feng M; Kong YG; Li SF
    Yao Xue Xue Bao; 2009 Nov; 44(11):1285-90. PubMed ID: 21355328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.